FDA Backs Off From Early Citations Of Compounder Sterility Issues

 
• By Bowman Cox

A month after compounding pharmacists' latest annual visit to Congress, FDA has acted on one of their chief complaints – investigators citing them for GMP violations even in cases where the agency later acknowledged they were exempt.

IACPMemberMeeting_MitchMcConnell
Former IACP President Michael Leake, Louisville, Ky., meets with Senate Majority Leader Mitch McConnell, R-Ky., as part of IACP's Compounders on Capitol Hill Day • Source: International Academy of Compounding Pharmacists

More from Manufacturing

More from Compliance